Unlock Premium Data: Up to 50% Off InvestingProCLAIM SALE

Nasdaq Falls 100 Points; AT&T Posts Upbeat Earnings

Published 19/10/2023, 19:37
© Reuters.  Nasdaq Falls 100 Points; AT&T Posts Upbeat Earnings
T
-

Benzinga - by Lisa Levin, Benzinga Editor.

U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite falling around 100 points on Thursday.

The Dow traded down 0.43% to 33,520.17 while the NASDAQ fell 0.75% to 13,214.04. The S&P 500 also fell, dropping, 0.62% to 4,287.95.

Check This Out: Best Buy To Rally More Than 21%? Here Are 10 Top Analyst Forecasts For Thursday

Leading and Lagging Sectors

Communication services shares climbed by 1% on Thursday.

In trading on Thursday, consumer discretionary shares fell by 1.7%.

Top Headline

AT&T Inc (NYSE: T) reported better-than-expected third-quarter financial results.

AT&T reported third-quarter FY23 operating revenues of $30.35 billion, up 1% year-over-year, beating the consensus of $28.69 billion. Adjusted EPS of $0.64 beat the consensus of $0.59.

AT&T now expects full-year adjusted EBITDA growth of better than 4% versus prior guidance of 3%+.

Equities Trading UP

SAB Biotherapeutics, Inc. (NASDAQ: SABS) shares shot up 27% to $0.7899 after the company announced it received Australian approval to commence the Phase 1 clinical trial of SAB-142.

Shares of Spectral AI, Inc. (NASDAQ: MDAI) got a boost, shooting 32% to $3.4099 after the company announced that its DeepView SnapShot Wound Imaging System was marked for use in the U.K. and received Class 1 medical device classification with the FDA.

PTC Therapeutics, Inc. (NASDAQ: PTCT) shares were also up, gaining 19% to $24.42 after the company announced an agreement with Royalty Pharma to monetize up to $1.5 billion of the Evrysdi Royalty Stream.

Equities Trading DOWN

Nxu, Inc. (NASDAQ: NXU) shares dropped 38% to $0.0431 after the company announced a $3 million public offering of common stock of 86 million shares at $0.035 per share.

Shares of Semtech Corporation (NASDAQ: SMTC) were down 22% to $15.45 after the company announced a $250 million private placement offering.

Generation Bio Co. (NASDAQ: GBIO) was down, falling 31% to $1.66 after TD Cowen downgraded the stock from Outperform to Market Perform.

Also Check This Out: Top 3 Financial Stocks You'll Regret Missing In Q4

Commodities

In commodity news, oil traded up 0.9% to $89.14 while gold traded up 0.8% at $1,984.50.

Silver traded down 0.3% to $23.03 on Thursday while copper rose 0.3% to $3.5985.

Euro zone

European shares closed lower today. The eurozone’s STOXX 600 fell 1.19%, London’s FTSE 100 fell 1.17% while Spain’s IBEX 35 Index fell 0.72% The German DAX fell 0.33% French CAC 40 declined 0.64%, while Italy’s FTSE MIB Index declined 1.38%.

The Eurozone recorded a current account surplus of EUR 30.67 billion in August versus a year-ago deficit of EUR 26.57 billion. Spain's trade deficit narrowed to EUR 4.4 billion in August from EUR 7.9 billion in the year-ago month. The manufacturing climate indicator in France fell to 98 in October versus 99 in the prior month.

Asia Pacific Markets

Asian markets closed lower on Thursday, with Japan’s Nikkei 225 falling 1.91%, China’s Shanghai Composite Index falling 2.46% and Hong Kong’s Hang Seng Index falling 1.74%. India’s S&P BSE Sensex, meanwhile, fell 0.25%.

Japan posted a trade surplus of JPY 62.44 billion in September compared to a deficit of JPY 2,099 billion in the year-ago period. Hong Kong's unemployment rate came in unchanged at 2.8% in the three months ending September. Average new home prices in China declined by 0.1% year-over-year in September.

Economics

The Philadelphia Fed Manufacturing Index rose -9 in October from -13.5 a month ago, versus market estimates of -6.4.

U.S. jobless claims declined by 13,000 from the previous week to 198,000 in the week ending October 14, compared to market expectations of 212,000.

U.S. natural-gas supplies climbed 97 billion cubic feet last week, the EIA said.

Now Read This: Vertex Pharmaceuticals, Gilead Sciences And 2 Other Stocks Insiders Are Selling

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.